Form 8-K MICROVISION, INC. For: Apr 27
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________
FORM 8-K
CURRENT
REPORT
Pursuant to
Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): April
27, 2016
______________
MICROVISION, INC.
(Exact
Name of Registrant as Specified in Charter)
Delaware |
001-34170 |
91-1600822 |
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
6244 185th
Avenue NE, Suite 100 |
(Address of Principal Executive Office) (Zip Code) |
Registrant’s
telephone number, including area code: (425) 936-6847
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. |
Results of Operations and Financial Condition. |
The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
On April 27, 2016, MicroVision, Inc. issued a press release announcing its First Quarter 2016 financial and operating results. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. |
Financial Statements, Pro Forma Financial Information and Exhibits. |
(c) |
Exhibits. |
|||
99.1 | MicroVision, Inc. Press Release Announces First Quarter 2016 Financial and Operating Results. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MICROVISION, INC. |
||||
|
||||
|
|
By: |
/s/ David J. Westgor |
|
|
David J. Westgor |
|||
|
Vice President, General Counsel & Secretary |
|||
|
||||
Date: |
April 27, 2016 |
Exhibit 99.1
MicroVision Announces First Quarter 2016 Results
Revenue grew 311 percent year-over-year and 100 percent sequentially
REDMOND, Wash.--(BUSINESS WIRE)--April 27, 2016--MicroVision, Inc. (NASDAQ: MVIS), a leader in innovative ultra-miniature projection display and imaging technology, today announced its financial and operating results for the first quarter of 2016 marked by significant year-over-year and sequential revenue growth.
MicroVision recorded its highest quarterly product and royalty revenue to date. MicroVision’s revenue in the first quarter 2016 was up 311 percent from the same quarter last year and 100 percent from the fourth quarter of 2015. Gross margin for the period of 30 percent was a significant improvement from the negative gross margin the company reported in the first quarter last year.
The following financial results are for the three months ended March 31, 2016, compared to the three months ended March 31, 2015.
- Revenue was $3.7 million compared to $0.9 million one year ago.
- Operating loss was $3.6 million, compared to a loss of $4.0 million for the same quarter one year ago.
- Net loss was $3.6 million, or $0.07 per share, compared to a loss of $4.0 million, or $0.09 per share for the same quarter one year ago.
- In the first quarter 2016 cash used in operations was $3.0 million compared to cash provided by operations of $5.1 million for the same period in 2015. Cash flow in the first quarter 2015 included the receipt of an $8 million license payment.
As of March 31, 2016, backlog was $9.2 million and cash and cash equivalents were $11.2 million. The cash balance includes funds received during the quarter of approximately $6.3 million from an offering of the company’s common stock.
Conference Call
The company will host a conference call today to discuss its first quarter 2016 results and current business operations at 8:30 a.m. ET / 5:30 a.m. PT. Participants may join the conference call by dialing 1-888-771-4371 (for U.S. participants) or +1-847-585-4405 (for international participants) ten minutes prior to the start of the call. The conference call pass code number is 42377657. A live webcast of the call can be accessed from the company’s web site in the Investor Events Calendar section on the Investor’s page. A replay of this call will be available after 8:00 a.m. PT the day of the conference call through the same link or by calling 1-888-843-7419 (U.S.) or +1-630-652-3042 (International), pass code 4237 7657#. The phone-in replay will be available until May 4, 2016.
About MicroVision
MicroVision is the creator of PicoP® scanning technology, an ultra-miniature laser projection and imaging solution based on the laser beam scanning methodology pioneered by the company. MicroVision’s platform approach for this advanced display and imaging solution means that it can be adapted to a wide array of applications and form factors. It is an advanced solution for a rapidly evolving, always-on world. Extensive research has led MicroVision to become an independently recognized leader in the development of intellectual property. MicroVision’s IP portfolio has been recognized by the Patent Board as a top 50 IP portfolio among global industrial companies and has been included in the Ocean Tomo 300 Patent Index. The company is based in Redmond, Wash.
For more information, visit the company’s website at www.microvision.com, on Facebook at www.facebook.com/MicroVisionInc or follow MicroVision on Twitter at @MicroVision.
MicroVision and PicoP are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.
Forward-Looking Statements
Certain statements contained in this release, including those relating to potential applications and features of MicroVision technology, and those containing words such as “expects” are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company’s forward-looking statements include the following: our ability to raise additional capital when needed; products incorporating our PicoP display engine may not achieve market acceptance, commercial partners may not perform under agreements as anticipated, we may be unsuccessful in identifying parties interested in paying any amounts or amounts we deem desirable for the purchase or license of IP assets, our or our customers’ failure to perform under open purchase orders; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market our products; potential product liability claims; and other risk factors identified from time to time in the company’s SEC reports, including the company’s Annual Report on Form 10-K filed with the SEC. Except as expressly required by federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.
MicroVision, Inc. | ||||||||||
Balance Sheet | ||||||||||
(In thousands) | ||||||||||
(Unaudited) | ||||||||||
March 31, | December 31, | |||||||||
2016 |
2015 |
|||||||||
Assets | ||||||||||
Current Assets | ||||||||||
Cash and cash equivalents | $ | 11,209 | $ | 7,888 | ||||||
Accounts receivable, net | 996 | 1,687 | ||||||||
Inventory | 906 | 862 | ||||||||
Other current assets | 590 | 638 | ||||||||
Total current assets | 13,701 | 11,075 | ||||||||
Property and equipment, net | 1,537 | 1,669 | ||||||||
Restricted cash | 435 | 435 | ||||||||
Intangible assets, net | 813 | 845 | ||||||||
Other assets | 18 | 18 | ||||||||
Total assets | $ | 16,504 | $ | 14,042 | ||||||
Liabilities and Shareholders' Equity (Deficit) | ||||||||||
Current Liabilities | ||||||||||
Accounts payable | $ | 2,354 | $ | 2,183 | ||||||
Accrued liabilities | 3,882 | 3,399 | ||||||||
Deferred revenue | 1,203 | 2,122 | ||||||||
Total current liabilities | 7,439 | 7,704 | ||||||||
Deferred revenue, net of current portion | 5,903 | 6,149 | ||||||||
Deferred rent, net of current portion | 304 | 342 | ||||||||
Total liabilities | 13,646 | 14,195 | ||||||||
Commitments and contingencies | ||||||||||
Shareholders' Equity (Deficit) | ||||||||||
Common stock at par value | 51 | 47 | ||||||||
Additional paid-in capital | 489,734 | 483,171 | ||||||||
Accumulated deficit | (486,927 | ) | (483,371 | ) | ||||||
Total shareholders' deficit | 2,858 | (153 | ) | |||||||
Total liabilities and shareholders' equity (deficit) | $ | 16,504 | $ | 14,042 | ||||||
MicroVision, Inc. | ||||||||||
Statement of Operations | ||||||||||
(In thousands, except earnings per share data) | ||||||||||
(Unaudited) | ||||||||||
Three months ended March 31, |
||||||||||
2016 |
2015 |
|||||||||
Product revenue | $ | 3,155 | $ | 741 | ||||||
Royalty revenue | 542 | 144 | ||||||||
Contract revenue | 4 | 16 | ||||||||
Total revenue | 3,701 | 901 | ||||||||
Cost of product revenue | 2,588 | 1,037 | ||||||||
Cost of contract revenue | 1 | 7 | ||||||||
Total cost of revenue | 2,589 | 1,044 | ||||||||
Gross margin | 1,112 | (143 | ) | |||||||
Research and development expense | 2,597 | 1,898 | ||||||||
Sales, marketing, general and administrative expense | 2,068 | 1,921 | ||||||||
Total operating expenses | 4,665 | 3,819 | ||||||||
Loss from operations | (3,553 | ) | (3,962 | ) | ||||||
Other income, net | (3 | ) | - | |||||||
Net loss | $ | (3,556 | ) | $ | (3,962 | ) | ||||
Net loss per share - basic and diluted | $ | (0.07 | ) | $ | (0.09 | ) | ||||
Weighted-average shares outstanding - basic and diluted | 47,566 | 44,963 |
CONTACT:
MicroVision, Inc.
Investors:
Dawn Goetter, 425-882-6629
[email protected]
or
Media:
Nicole
Cobuzio, 732-212-0823 ext. 102
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Methanex Corporation – Notice of Cash Dividend
- ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
- ROSEN, A RANKED AND LEADING FIRM, Encourages Innoviz Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INVZ, INVZW
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!